Am J Obstet Gynecol. 2022 Apr;226(4):B2-B9. doi: 10.1016/j.ajog.2021.11.1355. Epub 2021 Nov 25.
Hospital readmission is considered a core measure of quality in healthcare. Readmission soon after hospital discharge can result from suboptimal care during the index hospitalization or from inadequate systems for postdischarge care. For many conditions, readmission is associated with a high rate of serious morbidity and potentially avoidable costs. In obstetrics, for postpartum care specifically, hospitals and payers can easily track the rate of maternal readmission after childbirth and may seek to incentivize obstetricians, maternal-fetal medicine specialists, or provider groups to reduce the rate of readmission. However, this practice has not been shown to improve outcomes or reduce harm. There are major concerns with incentivizing providers to reduce postpartum readmissions, including the lack of a standardized metric, a baseline rate of 1% to 2% that is too low to accurately discriminate between random variation and controllable factors, the need for risk adjustment that greatly complicates rate calculations, the potential for bias depending on the duration of the follow-up interval, the potential for the "gaming" of the metric, the lack of evidence that obstetrical providers can influence the rate, and the potential for unintended harm in the vulnerable postpartum population. Until these problems are adequately addressed, maternal readmission rate after a childbirth hospitalization currently has limited utility as a metric for quality or performance improvement or as a factor to adjust provider reimbursement.
医院再入院被认为是医疗保健质量的核心衡量标准。出院后不久再次入院可能是由于指数住院期间护理不佳,也可能是由于出院后护理系统不完善。对于许多疾病,再入院与严重发病率和潜在可避免的成本高度相关。在产科,特别是产后护理方面,医院和支付方可以轻松跟踪产妇分娩后再次入院的比率,并可能试图激励妇产科医生、母胎医学专家或医疗服务提供者团体降低再入院率。然而,这种做法并没有显示出能改善结果或减少伤害。激励提供者降低产后再入院率存在重大问题,包括缺乏标准化指标、1%至 2%的基线率太低,无法准确区分随机变化和可控因素、需要风险调整,这极大地复杂化了比率计算、潜在的基于随访间隔时间的偏差、指标“操纵”的可能性、缺乏证据表明产科提供者可以影响该比率,以及脆弱的产后人群中潜在的意外伤害。在这些问题得到充分解决之前,分娩后住院患者的再入院率作为衡量质量或绩效改进的指标,或作为调整提供者报销的因素,其用途有限。